Boris Jan Nils Winterhoff MD , MS
Gynecologic Oncology
Physician
Join to View Full Profile
500 Harvard Street SEMinneapolis, MN 55455
Dr. Winterhoff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 2014- Mayo Clinic College of Medicine and Science (Rochester)Residency, Obstetrics and Gynecology, 2006 - 2010
Univ Kiel- Christian- Albrechts- Fac MedClass of 2005
Certifications & Licensure
WI State Medical License 2020 - 2027
MN State Medical License 2008 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014
Publications & Presentations
PubMed
- Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa W Jayawardana
Nature Communications. 2026-04-01 - Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomize...Blair V Landon, Julia L Boland, Andrea E Wahner Hendrickson, Deborah K Armstrong, Boris Winterhoff
Communications Medicine. 2026-02-06 - STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithel...Arpit Aggarwal, Morgann Madill, Mayukhmala Jana, Tilak Pathak, Timothy K Starr
BJC Reports. 2026-02-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
